生命早期1000天糖限制与成年MASLD及肝脏不良结局风险
基于英国生物银行数据的准自然实验显示,受英国糖配给政策(1942-1953)影响、在宫内及幼儿期经历糖限制的个体,成年后严重MASLD风险降低30%,主要不良肝脏结局降低35%,肝硬化降低32%,保护效应随暴露时间延长而增强,代谢综合征特征介导了60%以上的保护关联。
要点
- 生命早期糖限制与成年MASLD风险降低30%相关(HR 0.70,95%CI 0.58-0.85)。
- 糖限制与主要不良肝脏结局风险降低35%、肝硬化风险降低32%相关。
- 代谢综合征特征介导了60%以上的保护关联,支持代谢途径机制。
核心结论
- 生命关键发育窗口期的早期糖限制与成年MASLD及肝脏并发症风险降低相关,主要由代谢特征改善介导。
研究设计与样本
- 利用英国生物银行数据的准自然实验,比较宫内及幼儿期暴露于糖配给政策(1942-1953)者与配给结束后出生者,共63,698名参与者。
主要发现
- 宫内加1-2年暴露与MASLD风险降低30%相关(HR 0.70,95%CI 0.58-0.85)。
- 代谢功能障碍相关脂肪性肝病伴饮酒风险降低17%,主要不良肝脏结局降低35%,肝硬化降低32%。
- 保护效应随暴露时间延长而增强,代谢综合征特征解释了60%以上的保护关联。
- 配给组肝脏生物标志物和影像学改善:磁共振成像质子密度脂肪分数降低0.50%,cT1降低52.2 ms。
- 结果在PNPLA3、TM6SF2基因型及饮酒亚组中一致。
临床怎么用
- 提示针对妊娠期和幼儿期糖摄入的政策干预可能对肝脏和代谢健康产生持久获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The first 1000 days of life are critical for shaping long-term metabolic and organ health. We aimed to evaluate whether sugar restriction during the first 1000 days of life, due to the United Kingdom sugar rationing policy (1942-1953), reduced the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) and related liver outcomes in adulthood. METHODS: We conducted a quasi-natural experiment using UK Biobank data, comparing individuals exposed to sugar rationing in utero and early childhood with those born after rationing ended. Primary outcomes included severe MASLD, major adverse liver outcomes, cirrhosis, and liver cancer, with secondary outcomes assessed by biochemical and imaging biomarkers. Mediation analysis was performed to examine the role of metabolic syndrome traits. RESULTS: Among 63,698 participants, early-life sugar rationing was associated with a 30% reduced risk of MASLD (hazard ratio, 0.70; 95% confidence interval, 0.58-0.85 for in utero plus 1-2 years exposure), 17% lower risk of metabolic dysfunction-associated steatotic liver disease with alcohol consumption, 35% for major adverse liver outcomes, and 32% for cirrhosis. The protective effect increased with longer exposure. Mediation analysis indicated that metabolic syndrome traits explained over 60% of the protective association. Improved liver biomarkers and imaging findings (magnetic resonance imaging-proton density fat fraction reduced by 0.50% and cT1 by 52.2 ms) in the rationed group supported these results. Findings were consistent across genotypes (PNPLA3, TM6SF2) and alcohol intake (metabolic dysfunction-associated steatotic liver disease with alcohol consumption) subgroups. CONCLUSIONS: Early-life sugar restriction during critical developmental windows is associated with lower adult risk of MASLD and liver complications, primarily mediated by improved metabolic profiles. Policy efforts targeting sugar intake in pregnancy and early childhood may provide durable benefits for liver and metabolic health.
引用
- Zheng J, Zhou Z, Huang J, et al. Sugar Rationing in the First 1000 Days After Conception and Long-Term Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Major Adverse Liver Outcomes: A Natural Experiment Study. Clin Gastroenterol Hepatol. 2025. PMID: 41284512. doi:10.1016/j.cgh.2025.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。